The Bottom Line BPC-157 and alcohol is one of the better-studied combinations in peptide research
In terms of type 2 diabetes, studies have demonstrated that BPC-157 can decrease glucose levels and increase insulin sensitivity, thus helping to improve glycemic control
It also avoids the small carbohydrate hit that flavored versions carry clean compatibility with ketogenic anticancer protocols
The honest position is that peptides are an active research area, knee-specific evidence is limited, and the regulatory picture in Australia is more restrictive than the marketing suggests
We are delighted to be partnering with Australias leading pharmacy retailer to make our products more accessible to a wider audience across Australia, said Fernando Rodriguez, CEO at Eaoron
Treatment is 10 mg daily for 10 days, followed by 10 mg monthly for life